27 September 2020
US Patient Engagement Solutions Market Forecast 2020-2030: Forecasts and Analysis By Delivery Type, By Component, By Application, By End-Use and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial U.S. Patient Engagement Solutions sector analysis.
According to the report published by Visiongain, the U.S. Patient Engagement Solutions market was valued at approximately USD xx billion in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. The market is expected to contribute to the high prevalence of chronic diseases and the emphasis of clinicians on self-management. Continuing to boost growth is expected to accompany increasing medical tourism in developing countries with the increased use of cloud-based network models and investment in health IT.
Promoting business dynamics are expected through supportive government legislation and marketing campaigns. For example, the Centers for Medicare and Medicaid Services (CMS) Readmission Reduction Program inspires providers to actively engage with patient involvement solutions to contain readmission rates whilst improving hospitable care. The Affordable Care Act (ACA) also encourages market growth through the implementation of services, such as the Healthcare Providers and Services Customer Survey (HCAHPS) in hospitaux, for the intent of administering surveys that gather information relevant to facility and system patient satisfaction. This is a tool for standardizing the quality of hospital care measurement.
U.S. Patient Engagement Solutions Market is witnessing Growth due to factors such as
The Increasing Importance of Patient Engagement
The patients ' contribution has become critically important in today's medical climate, in which emphasis is placed on advancing value-based treatment systems and optimizing quality. The topic has been covered by countless articles, blogs, studies and educational forums, some arguing that no other short-term initiative will have greater impact on the quality of patient care and the cost of medical care reduction. Patient satisfaction is now seen as a key strategy for meeting the triple goal of healthcare–optimum quality, outcomes and efficacy.
Successful participation cannot be accomplished however without the ability of clinicians to share in public decision-making and to participate actively in their ongoing health care. Importantly, clinicians ' transparent participation and self-management have been shown to be improved by acts that customize their literacy. The study suggests that patients are more likely to build confidence in their self-management capacity and to identify and communicate health problems after gaining personalized knowledge, such as understanding medicines and their dosages and the importance of PCP follow-up appointments. The challenge to the healthcare system remains how to implement patient engagement solutions that efficiently engage and activate individual patients.
Patient Engagement and the Bottom Line
Recent economic and political pressure has accelerated the exploration of methods for improving the quality and cost-effectiveness of health care, including the implementation of the Affordable Care Act. Readmissions in clinics, for example, lead to a heavy workload on both health and clinical care systems. In the US, approximately 20% of patients were re-admitted within 30 days of release, an estimated cost of USD 17 billion annually. The quest for cost savings and changes in reliability has escalated owing to these readmissions, previously thought to be a concern which mostly was related to medication non-compliance and other stresses. Patient engagement is a key component in increasing effectiveness throughout the whole of the patient's journey — implemented properly by patient engagement, the quality of patients can be increased and cost reductions can be applied to the whole care spectrum. About two thirds of the respondents (63 percent), who participate in the latest Insights Council survey by NEJM Catalyst, refer to time spending as the greatest challenge for healthcare teams to integrate patient participation in care. In general, doctors are often forced to see more and more patients only to maintain current income in their practices. As a consequence, although that engagement in healthcare is deemed to be worthwhile, the practicality of further outreach is overwhelming–doctors are already extending their way through simultaneously caring for patients, teaching, adhering to complicated schemes such as substantive use and PQRS, and handling improvements likeICD-10. Many providers are looking for external solutions to increase patient involvement with these challenges.
Although there is still a dedication to customer satisfaction, organizations are changing. The comprehensive study has shown that almost nine out of 10 organizations have adopted a patient experience plan, including feedback from leadership in multihospital unified delivery systems (44 percent), health schools (21percent), hospitals (21 percent), ambulatory clinics (13 percent) and critical access hospitals (1 percent).
The presence of clinicians is more and more defined by encounters during patient travel, including prior, during and after care experiences. Increased patient engagement contributes to gains, including improved research outcomes, decreased healthcare costs, increased emphasis on mitigation and greater satisfaction for clinicians. The effective involvement of patients is however complex and requires the correct person with the right signals and input loops at the right time. New models for patient engagement are emerging to address these complexities and respond to the growing requirements for better clinical and financial results.
The chronic diseases, nutrition, women wellbeing, mental health and other areas are categorized as the care section. It is estimated that the chronic disease group will have a profit share of roughly 45.0 per cent. The market is expected to witness a lucrative growth during the forecast period to raise the prevalence of chronic conditions such as obesity, AIDS and cancer coupled with the increasing of the geriatric and child population. The market will also be boosted by improved patient understanding of self-care and health.
The Office of the national health information technology coordinator's (ONC) is expected to fuel a growing awareness of patient engagement solutions among government organizations such as the Health Research and Quality Agency. The increased use of mobile health is seen as the main driver in the United States. Market solutions to patient engagement. Increased sensitization and the need for personal health monitoring have resulted in an increased use of mobile health applications globally. The market is divided into the form, component, end-use, product and therapeutic area of the supply.
In contrast to the extensive expansion of unbroken 3 G and 4 G networks, growing proliferation in mobiles such as smartphones and smart phones increasingly facilitates digital wellbeing. The use of mobile applications has proved to be highly effective in sensitizing the causative, preventive and healing agents of chronic diseases and thus driving growth in the market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.
29 September 2022
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
21 September 2022
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
16 September 2022
The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.